Next 10 |
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, chairman and chief execut...
2024-05-25 03:01:27 ET Summary Myomo is a wearable medical robotics company that designs and manufactures orthotics for people with neurological disorders. The company's stock performance has been disappointing, losing almost all of its value since going public in 2017. Despit...
2024-05-20 10:00:07 ET Ben Haynor from Lake Street issued a price target of $7.00 for MYO on 2024-05-20 08:41:00. The adjusted price target was set to $7.00. At the time of the announcement, MYO was trading at $3.64. MYO currently trades -34.77% versus its 52 week high o...
2024-05-08 22:03:09 ET Myomo, Inc. (MYO) Q1 2024 Earnings Conference Call May 08, 2024 04:30 PM ET Company Participants Kim Golodetz - LHA Investor Relations Paul Gudonis - Chief Executive Officer Dave Henry - Chief Financial Officer Conference Call Partici...
2024-05-08 16:33:11 ET More on Myomo Myomo's Revolutionary MyoPro Brace: A Buy In Neurological Mobility Aid Myomo, Inc.: In Motion To Accelerating Revenue Growth Myomo, Inc. (MYO) Q4 2023 Earnings Call Transcript Myomo gets first lump sum reimbursements for M...
Record 275 patients in backlog, includes 180 authorizations and orders in Q1, up 48% over the prior year Record 493 MyoPro candidates added to the pipeline in Q1 Revenue of $3.8 million, up 9% over the prior year Conference call begins at 4:30 p.m. Eastern time today ...
2024-05-06 10:14:46 ET More on Myomo Myomo's Revolutionary MyoPro Brace: A Buy In Neurological Mobility Aid Myomo, Inc.: In Motion To Accelerating Revenue Growth Seeking Alpha’s Quant Rating on Myomo Read the full article on Seeking Alpha For f...
Claims Remitted for Payment by All Four Billing Regions Orthotics and Prosthetics Providers Beginning to Receive Reimbursement at Published Rates Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that...
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for th...
Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Heather Getz as a Class II director and chair of its ...
News, Short Squeeze, Breakout and More Instantly...
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that Paul Gudonis, chairman and chief execut...
2024-05-20 10:00:07 ET Ben Haynor from Lake Street issued a price target of $7.00 for MYO on 2024-05-20 08:41:00. The adjusted price target was set to $7.00. At the time of the announcement, MYO was trading at $3.64. MYO currently trades -34.77% versus its 52 week high o...
Record 275 patients in backlog, includes 180 authorizations and orders in Q1, up 48% over the prior year Record 493 MyoPro candidates added to the pipeline in Q1 Revenue of $3.8 million, up 9% over the prior year Conference call begins at 4:30 p.m. Eastern time today ...